Application 077221
- Type
- ANDA
- Sponsor
- CIPLA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LAMIVUDINE | LAMIVUDINE | TABLET;ORAL | 150MG | No | No |
| 002 | LAMIVUDINE | LAMIVUDINE | TABLET;ORAL | 300MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A077221-001 | LAMIVUDINE | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2017-03-03 | |
| A077221-002 | LAMIVUDINE | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2017-03-03 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A077221-001 | AB |
| A077221-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A077221-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2017-03-03 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A077221-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2017-03-03 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A077221-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2017-03-03 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A077221-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2017-03-03 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A077221-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2017-03-03 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A077221-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2017-03-03 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077221-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2017-03-03 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077221-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2017-03-03 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A077221-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2017-03-03 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A077221-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2017-03-03 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077221-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2017-03-03 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077221-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2017-03-03 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077221-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2017-03-03 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077221-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2017-03-03 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077221-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2017-03-03 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077221-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2017-03-03 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077221-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2017-03-03 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077221-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2017-03-03 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077221-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2017-03-03 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077221-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2017-03-03 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A077221-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2017-03-03 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A077221-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2017-03-03 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A077221-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2017-03-03 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A077221-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2017-03-03 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A077221-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2017-03-03 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A077221-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2017-03-03 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A077221-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2017-03-03 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A077221-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2017-03-03 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A077221-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2017-03-03 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A077221-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2017-03-03 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A077221-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2017-03-03 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A077221-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2017-03-03 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A077221-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2017-03-03 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A077221-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2017-03-03 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A077221-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2017-03-03 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A077221-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2017-03-03 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A077221-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2017-03-03 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A077221-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2017-03-03 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A077221-001 | LAMIVUDINE | 150MG | TABLET / ORAL | AB | 2017-03-03 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A077221-002 | LAMIVUDINE | 300MG | TABLET / ORAL | AB | 2017-03-03 | 74a2ff9319b5… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A077221-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A077221-002 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A077221-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A077221-002 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A077221-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A077221-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077221-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A077221-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A077221-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A077221-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077221-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A077221-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077221-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A077221-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077221-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A077221-002 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077221-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A077221-002 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077221-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A077221-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A077221-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A077221-002 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A077221-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A077221-002 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A077221-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A077221-002 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A077221-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A077221-002 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A077221-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A077221-002 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A077221-001 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A077221-002 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A077221-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A077221-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A077221-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A077221-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A077221-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A077221-002 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A077221-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A077221-002 | AB | 1 | 74a2ff9319b5… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lamivudine | LAMIVUDINE | Camber Pharmaceuticals, Inc. | 6bd6b9da-df69-46db-813e-4e7f3bdecf95 | 2026-07-29 | Boxed warning, Warnings, Adverse reactions | Lamivudine LAMIVUDINE |
| LAMIVUDINE | LAMIVUDINE | Major Pharmaceuticals | 6fd4d6b9-65ea-4988-8d6f-dd220ec5052d | 2026-03-13 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Strides Pharma Science Limited | ac824c7e-9c9f-487b-ad2f-d50eaef5cbda | 2026-01-05 | Boxed warning, Warnings, Adverse reactions | Lamivudine LAMIVUDINE |
| lamivudine | LAMIVUDINE ORAL | Chartwell Govermental & Specialty RX, LLC. | b23aea53-324b-4ff2-8736-639e4045e388 | 2026-01-02 | Boxed warning, Warnings, Adverse reactions | lamivudine |
| lamivudine | LAMIVUDINE ORAL | Chartwell RX, LLC | ef9977cb-ec91-46d7-b769-d26decfd6fe7 | 2025-12-30 | Boxed warning, Warnings, Adverse reactions | lamivudine |
| LAMIVUDINE | LAMIVUDINE | Golden State Medical Supply, Inc. | f3637209-303e-4232-ae79-07315a990973 | 2025-11-24 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE LAMIVUDINE |
| LAMIVUDINE | LAMIVUDINE | Apotex Corp. | 34c02bcc-d6ff-99d4-8e6a-4a91908adca8 | 2025-09-19 | Boxed warning, Warnings, Adverse reactions | LAMIVUDINE LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Golden State Medical Supply, Inc. | 3c30216d-f9f5-104b-e063-6294a90af8fd | 2025-08-12 | Boxed warning, Warnings, Adverse reactions | Lamivudine LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Apotex Corp. | 87095352-c088-74b1-7be0-d3e293a90611 | 2025-06-17 | Boxed warning, Warnings, Adverse reactions | Lamivudine LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Coupler LLC | 2d7db3b2-9b3c-3031-e063-6294a90a342c | 2025-02-06 | Boxed warning, Warnings, Adverse reactions | Lamivudine LAMIVUDINE |
| lamivudine | LAMIVUDINE | Camber Pharmaceuticals, Inc. | e90671c6-7fff-48f4-8898-29f02d049c8b | 2025-01-09 | Boxed warning, Warnings, Adverse reactions | lamivudine LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Camber Pharmaceuticals, Inc. | 49d53e74-3798-4463-b817-1c8beb755034 | 2025-01-09 | Boxed warning, Warnings, Adverse reactions | Lamivudine LAMIVUDINE |
| Lamivudine | LAMIVUDINE | American Health Packaging | 7ad3a998-8e4d-43a0-8930-8f7a6ae539b4 | 2024-09-16 | Boxed warning, Warnings, Adverse reactions | Lamivudine LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Aurobindo Pharma Limited | a8a492ab-396a-4b7c-99b3-bcb6d3386f71 | 2024-04-29 | Boxed warning, Warnings, Adverse reactions | Lamivudine LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Rising Pharma Holdings, Inc. | bed2e227-8d36-40ea-bbbf-d8793bfda425 | 2024-04-16 | Boxed warning, Warnings, Adverse reactions | Lamivudine LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Aurobindo Pharma Limited | ba7ee31e-e8d4-4e17-b27a-d2ce69e3bb00 | 2024-04-16 | Boxed warning, Warnings, Adverse reactions | Lamivudine LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Lupin Pharmaceuticals, Inc. | ff3b5265-f533-4332-a861-d8c9c1664ffd | 2024-01-03 | Boxed warning, Warnings, Adverse reactions | Lamivudine LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Macleods Pharmaceuticals Limited | 1be30bcc-2d9f-4afc-8f09-adc840b3f2d9 | 2022-12-01 | Boxed warning, Warnings, Adverse reactions | Lamivudine LAMIVUDINE |
| Lamivudine | LAMIVUDINE | Ingenus Pharmaceuticals, LLC | 47f8be59-178c-4bad-96a4-a5c82784f308 | 2018-12-24 | Boxed warning, Warnings, Adverse reactions | Lamivudine LAMIVUDINE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 69097-166 | LAMIVUDINE | LAMIVUDINE | Cipla USA Inc. | ANDA | Current |
| 69097-166 | LAMIVUDINE | LAMIVUDINE | Cipla USA Inc. | ANDA | Current |
| 69097-167 | LAMIVUDINE | LAMIVUDINE | Cipla USA Inc. | ANDA | Current |
| 69097-167 | LAMIVUDINE | LAMIVUDINE | Cipla USA Inc. | ANDA | Current |